SavedAdd your journal

Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 1995 / Cilt: 48 - Sayı: 1

Seroconversion rates with recombinant hepatitis B vaccine in preexposure prophylaxis

Rekombinant hepatit B aşısı ile temas öncesi profilakside serokonversiyon oranlarının araştırılması

Semih KANDİLCİ
Lale KARAAĞAÇLIOĞLU
Fügen ÇOKÇA
Pages
119–122
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After the first, second and third vaccine injections, the seroconversion rates were 36 %, 88 % and 100 %, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:in our study 36 students of Faculty of Dental Surgery were given recombinant hepatitis B vaccine intramuscularly by 0-1-2-12 schedule.
📊
Key Findings & Data:After one month of each vaccine dose, blood samples were taken and tested for protective antibody levels.
💡
Conclusion & Impact:After the first, second and third vaccine injections, the seroconversion rates were 36 %, 88 % and 100 %, respectively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

in our study 36 students of Faculty of Dental Surgery were given recombinant hepatitis B vaccine intramuscularly by 0-1-2-12 schedule. After one month of each vaccine dose, blood samples were taken and tested for protective antibody levels. After the first, second and third vaccine injections, the seroconversion rates were 36 %, 88 % and 100 %, respectively.

Özet

Çalışmamızda 36 Diş Hekimliği Fakültesi öğrencisine, 0-1-2-12 şe¬ması ile intramüsküler yoldan rekombinant hepatit B aşısı yapıldı. Her aşı dozundan bir ay sonra kan örneği alınarak koruyucu antikor dü¬zeyleri araştırıldı. Birinci, ikinci ve üçüncü aşıları takiben elde edilen serokonversiyon oranlan sırasıyla % 36, % 88 ve % 100 idi.

🔖

Cite This Article

KANDİLCİ, S., KARAAĞAÇLIOĞLU, L., ÇOKÇA, F. (2022). Seroconversion rates with recombinant hepatitis B vaccine in preexposure prophylaxis. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 48 - Sayı: 1, 119–122. https://ajindex.com/articles/444330

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Ahman L Back E Bensch K Olcen P: Nnn efficacy of low dose intradermal vaccination against hepatitis B iıı Down's syndrome Ccand J Infect Dis 25: 16-23, 1993
  2. Bilgiç A: Hepatit B'den özgül korunma Viral Hepatit (Ed. Kılıçturgay K) Viral Hepatitle Savaşım Derneği Yayını s. 87-104, 1992
  3. Choudhury RP Cleator SJ: An examinatıon of needlestick injury rates, hepa-titis B vaccination uptake and instruction on sharp technique among medical students J Hosp Infect 22: 143-148, 1992
  4. Hail CB Halsey NA: Control of hepatitis B. Pediatrics 29: 274-277, 1992
  5. Mahoney FJ Woodruff BA Erben JJ Coleman PJ Reid EC Schatz GC Kane MA; Effect of a hepatitis B vaccination program on the prevalence of hepatitis B viruş infection J Infect Dis 167: 203-207, 1993
  6. Margolis HS: Prevention of acute and chronic liver disease through immuniza-tion J Infect Dis 168: 9-14, 1993
  7. Milne A Waldon J: Recombinant DNA hepatitis B vaccination in teenagers J Infect Dis 166: 942, 1992
  8. Schaffner W Gardner P Gross PA: Hepatitis B immunization strategies Ann Intern Med 118 (4): 308-309, 1993
  9. Stevens CE Toy PT Taylor PE Lee T Yip HY: Prospects for control of hepatitis B virüs infection Pediatrics 90: 170-173, 1992
  10. Stites DP Rodgers RPC: Clinical Laboratory Methods for Detection of Antigens and Antibodies In Basic and Clinical Immunology (Ed. Stites DP, Terr Al) 7th Ed. Prentice-Hall International Inc. pp. 217-262, 1991.